Kathryn Benesh
CIK 1976318 · last filed 2026-06-29
Kathryn Benesh is a corporate insider who has filed 4 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing shows the insider was granted $145.1K of CME on Jun 29, 2026. Current disclosed insider exposure totals $788.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$788.3K
1
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CME | Director | 2,751 | $286.45 | $788.3K | $0 | 4 | 2026-06-29 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-29 | CME | Grant (A) | +645 | $145.1K | EDGAR |
| 2025-06-26 | CME | Grant (A) | +532 | $145.3K | EDGAR |
| 2024-06-26 | CME | Grant (A) | +748 | $145.2K | EDGAR |
| 2023-06-28 | CME | Grant (A) | +811 | $145.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.